The project METASIN’s main objective is to research and develop ready to market multifunctional active ingredients, foods and nutritional complements, which are able to have on influence on the pathologies and risk factors associated to the metabolic syndrome. The aim is to improve the quality of life of the targeted population in an integral way, generating new business opportunities for the F&B companies.
Metabolic syndrome is a clustering of at least three of five of the following medical conditions: abdominal (central) obesity, elevated blood pressure, elevated fasting plasma glucose, high serum triglycerides, and low high-density lipoprotein (HDL) levels. It is is associated with the risk of developing the following diseases:
The products developed within METASIN will be a natural alternative to the metabolic syndrome’s treatment, the so called “21st century epidemic”.